SILO PHARMA, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
SILO PHARMA, INC. (SILO) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $10.15 million as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2021-11-10
- 2021-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $10.15M.
- 2021-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.77M.
- 2021-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4.23M.
- 2020-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1.28M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2021-09-30 | $10.15M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $3.77M 10-Q · filed 2021-11-10 |
| 2021-03-31 | $4.23M 10-Q · filed 2021-11-10 |
| 2020-12-31 | $1.28M 10-Q · filed 2021-11-10 |
| 2020-09-30 | $2.07M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $2.30M 10-Q · filed 2021-11-10 |
| 2020-03-31 | -$261.77K 10-Q · filed 2021-11-10 |
| 2019-12-31 | -$22.89K 10-Q · filed 2021-11-10 |
| 2012-09-30 | -$29.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | -$20.45K 10-Q · filed 2012-08-01 |
| 2012-03-31 | -$14.79K 10-Q · filed 2012-05-15 |
| 2011-12-31 | -$1.75K 10-Q · filed 2012-11-13 |
| 2011-09-30 | $4.58K 10-Q · filed 2011-11-10 |
| 2011-06-30 | $22.30K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $47.48K 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |